drugset / Trial / NCT00717275
Study of Temozolomide to Treat Newly Diagnosed Brain Metastases
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if administering temozolomide after completion of stereotactic radiosurgery helps control existing brain metastases and prevents the developement of new brain metastases.
Timeline
- Start
- 2008-09
- Primary completion
- 2011-01
- Completion
- 2011-06
Outcome
Outcome not reported
Stopped (Enrollment): “Slow accrual.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | 75 mg/m2 | Oral |